Spectrophotometric determination of piroxicam via chelation with fe(III) in commercial dosage forms

Journal of the Chinese Chemical Society

Volumn 56, Issue 6, 2009, Pages 1083-1091

  Azmi, Syed Najmul Hejaz ^a   Iqbal, Bashir ^a   Jaboo, Muna Ahmed Mohad ^a   Al Shahari, Warda Ali Said ^a   Rahman, Nafisur ^b  

^a HIGHER COLLEGE OF TECHNOLOGY   (Oman)

^b ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Fe(III); Piroxicam; Spectrophotometry; Validation

Indexed keywords

EID: 77952374149     PISSN: 00094536     EISSN: None     Source Type: Journal    
DOI: 10.1002/jccs.200900157     Document Type: Article

References (31)

1. Her Majesty Stationary Office, British Pharmacopoeia; Royal Pharmaceutical Society of Great Britain: London, 2002; Vol.I, p 939.
2. The United States Pharmacopoeial Convention, The United States Pharmacopeia, 31st ed.; Rockville,MD, USA, 2008; p 3014.
3. Royal Pharmaceutical Society of Great Britain, British National Formulary, British Medical Association: London, UK, 2004; p 476.
4. Puthli, S. P.; Vavia, P. R. J. Pharm. Biomed. Anal. 2000, 22, 673.
5. Dadashzadeh, S.; Vali, A. M.; Rezagholi, N. J. Pharm. Biomed. Anal. 2002, 28, 1201.
6. Yrita, M.; Parra, P.; Fernańdez, J. M.; Barbanoj, J. M. J. Chromatogr. A 1999, 846, 199.
7. de Jager, A. D.; Ellis, H.; Hundt, H. K. L.; Swart, K. J.; Hundt, A. F. J. Chromatogr. B 1999, 729, 183.
8. Maya, M. T.; Pais, J. P.; Morais, J. A. J. Pharm. Biomed. Anal. 1995, 13, 319.
9. Avgerinos, A.; Axarlis, S.; Dragatsis, J.; Karidas, T.; Malamataris, S. J. Chromatogr. B 1995, 673, 142.
10. Donato,M. G.; Baeyens,W.; Van den Bossche,W.; Sandra, P. J. Pharm. Biomed. Anal. 2002, 28, 1201.
11. Acuna, J. A.; de la Fuente, C.; Vazquez, M. D.; Tascon, M. L. Talanta 1993, 40, 1637.
12. Rizk, M.; Ibrahim, F.; Hefnawy, M.; Nasr, J. J. J. Chin. Chem. Soc. 2006, 53, 767.
13. Damiani, P. C.; Bearzotti, M.; Cabezon, M.; Olivieri, A. C. J. Pharm. Biomed. Anal. 1998, 17, 233.
14. Manzoori, J. L.; Amjadi, M. Microchim. Acta 2003, 143, 39.
15. Amin, A. S. J. Pharm. Biomed. Anal. 2002, 29, 729.
16. El-Ries, M. A.;Mohamed, G.; Khalil, S.; El-Shall, M. Chem. Pharm. Bull. 2003, 51, 6.
17. Nagaralli, B. S.; Seetharamappa, J.; Melwanki, M. B. J. Pharm. Biomed. Anal. 2002, 29, 859.
18. El-Didamony, A. M.;Amin, A. S. Anal. Lett. 2004, 37, 1151.
19. El-Ries, M. A. Anal. Lett. 1998, 31, 793.
20. Siddappa, K.; Mallikarjun, M.; Reddy, T.; Tambe, M. J. Chin. Chem. Soc. 2008, 55, 1062.
21. Rahman, N.; Ahmad, Y.; Azmi, S. N. H.; Sulaiman, S. A. J. J. Chin. Chem. Soc. 2008, 55, 1357.
22. Rahman, N.; Bano, Z.; Azmi, S. N. H. J. Chin. Chem. Soc. 2008, 55, 557.
23. El-Moghazy, S. M.; Mohamed, M. A. E.-M; Mohamed, M. F.; Youssef, N. F. J. Chin. Chem. Soc. 2009, 56, 360.
24. Kamyabi, M. A. J. Chin. Chem. Soc. 2009, 56, 142.
25. Khaled, E. Talanta 2008, 75, 1167.
26. Rahman, N.; Bano, Z.; Azmi, S. N. H. Chem. Pharm. Bull. 2008, 56, 995.
27. International Conference on Harmonisation, Food and Drug Administration, Rockville, MD, USA, March 1, 1995. ICH Harmonised Tripartite Guideline - Text on Validation of Analytical Procedures, Fed. Regist; Department of Health and Human Services: Rockville, USA, 1995, 60, 11260.
28. Likussar,W.; Boltz, D. F. Anal. Chem. 1971, 43, 1265.
29. Hartmann, C.; Smeyers-Verbeke, J.; Penninckx, W.; Heyden, Y. V.; Venkeerberghen, P.;Massart, D. L. Anal. Chem. 1995, 67, 4491.
30. Canada Health Protection Branch, Drugs Directorate Guidelines, Acceptable Methods, Ministry of National Health and Welfare, Draft, 1992.
31. Sadeghi, S.; Mohammadzadeh, D.; Imampur, J. S. Anal. Bioanal. Chem. 2005, 383, 261.